Publikationen

Publikationen

    2020

    • Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, Lübke M, Bauer J, Rieth J, Wacker M, Peter A, Hörber S, Traenkle B, Kaiser PD, Rothbauer U, Becker M, Junker D, Krause G, Strengert M, Schneiderhan-Marra N, Templin MF, Joos TO, Kowalewski DJ, Stos-Zweifel V, Fehr M, Rabsteyn A, Mirakaj V, Karbach J, Jäger E, Graf M, Gruber LC, Rachfalski D, Preuss B, Hagelstein I, Märklin M, Bakchoul T, Gouttefangeas C, Kohlbacher O, Klein R, Stevanovic S, Rammensee HG, Walz JulianeS. (2020) SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat Immunol n/a(n/a): n/a.

    • Bohm K, Strompl J, Krumbholz A, Zell R, Krause G, Sievers C (2020) Establishment of a highly sensitive assay for detection of Hepatitis E virus-specific immunoglobulins. J Clin Microbiol 58(2).

    2019

    • Grylka-Baeschlin S, Clarke M, Begley C, Daly D, Healy P, Nicoletti J, Devane D, Morano S, Krause G, Karch A, Savage G, Gross MM (2019) Labour characteristics of women achieving successful vaginal birth after caesarean section in three European countries. Midwifery 74:(n/a): 36-43.

    • Wicker E, Lander F, Weidemann F, Hufnagel M, Berner R, Krause G (2019) Group B Streptococci: Declining Incidence in Infants in Germany. Pediatr Infect Dis J 38(5): 516-519.

    2018

    • Bohm K, Krause G, Sievers C (2018) Response to comment on: Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology. Vaccine 36(27): 3885.

    • Dreyer H, Grischke J, Tiede C, Eberhard J, Schweitzer A, Toikkanen SE, Glockner S, Krause G, Stiesch M (2018) Epidemiology and risk factors of peri-implantitis: A systematic review. J Periodontal Res 53(5): 657-681.

    2017

    • Bohm K, Filomena A, Schneiderhan-Marra N, Krause G, Sievers C (2017) Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology. Vaccine 35(43): 5883--5889.